ARTES Biotechnology

Contact
artes-biotechnology.com
+49 2173 27587-0

ARTES Biotechnology GmbH

Elisabeth-Selbert-Str. 9
40764 Langenfeld
Germany
+49 2173 27587-0
artes-biotechnology.com
Contact
Profile Products News
Contact

About ARTES Biotechnology

ARTES Biotechnology GmbH is a service provider for production and optimisation of microbial recombinant protein strains, especially with the yeast organisms Hansenula and Arxula. The independent company, founded in 2002, holds worldwide patents and licences for these and further technology platforms. ARTES` team is engaged in the production of recombinant proteins for clients in White Biotechnology (food and/ feed industry as well as/ fine chemical enzyme manufacturers industry) and in Red Biotechnology (pharmaceutical industry).

Read more about ARTES Biotechnology
Facts about ARTES Biotechnology
  • Founding: 2002
  • Focus : Service
  • Employees: 11-50
  • Industry : Biotechnology

Product portfolio of ARTES Biotechnology

Product portfolio

Show all

Similar companies

Biointron Biological Inc.

Biointron Biological Inc.

Metuchen
Service
Biotechnology
Search companies
Biointron Biological Inc.

Biointron Biological Inc.

Metuchen
Service
Biotechnology
Search companies

News about ARTES Biotechnology

ARTES Biotechnology

07-Oct-2014 | business & finance

ARTES Biotechnology, instrAction and Q-Biologicals Join Forces for Veterinary Vaccine Development

ARTES Biotechnology, InstrAction and Q-Biologicals establish a three-party consortium for vaccine developments for veterinary applications. Under the title ...

Read news
ARTES Biotechnology

16-Jul-2013 | business & finance

ARTES Biotechnology and Bio Farma Announce Collaboration in Vaccine Development

ARTES and Bio Farma announced to join forces for the development and manufacturing of vaccine candidates. The agreed collaboration involved the strength of ...

Read news
ARTES Biotechnology

06-Sep-2011 | research and development

ARTES Biotechnology GmbH and NL Biotechnologies LLC join in a strategic collaboration and co-marketing alliance

ARTES Biotechnology and NL Biotechnologies started a strategic collaboration. With signing this collaboration agreement the two companies combine their ...

Read news
ARTES Biotechnology

29-Sep-2010 | business & finance

ARTES Steps Further Into the Vaccine Business by Acquiring Anavax

ARTES Biotechnology announced the acquirement of the ANAVAX virus-like particle (VLP) technology from Select Vaccines Ltd. ANAVAX is a patent-protected VLP ...

Read news
ARTES Biotechnology

04-May-2010 | business & finance

Q Chip and ARTES Biotechnology announce collaboration to develop sustained release formulations of therapeutic proteins

Q Chip Ltd and ARTES Biotechnology GmbH announced that they have signed a Collaborative Agreement to explore the development of a new sustained release ...

Read news
ARTES Biotechnology

17-Nov-2009 | business & finance

ARTES and Rhein Minapharm continue their successful product development collaboration

ARTES Biotechnology and Rhein Minapharm Biogenetics, a subsidiary of Minapharm SAE, jointly announced the successful production of a new target of a ...

Read news
ARTES Biotechnology

15-Jan-2008 | business & finance

ARTES and Minapharm sign long-term strategic development agreement

ARTES Biotechnology and Rhein Minapharm Biogenetics, a subsidiary of Minapharm SAE jointly announced the start of a strategic collaboration to develop ...

Read news
ARTES Biotechnology

20-Jun-2006 | business & finance

ARTES Biotechnology GmbH and ProteoNic BV start research collaboration

ARTES Biotechnology GmbH, Germany, and ProteoNic B.V., The Netherlands, announced the start of their research collaboration. Both companies will join ...

Read news
Show more news about ARTES Biotechnology

Here you will find ARTES Biotechnology GmbH